This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "hemolytic_anemia_erythrocyte_destruction#Premature Erythrocyte Destruction"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should include the corresponding cell types, biological processes, and causal edges, specialized to their primary lesion. Key disorder-specific substitutions: hereditary spherocytosis substitutes a defective membrane/cytoskeletal protein (ankyrin-1, band 3, spectrin) at the trigger node; G6PD and pyruvate kinase deficiency substitute the deficient enzyme; sickle cell disease and thalassemia substitute the abnormal hemoglobin and add ineffective erythropoiesis; autoimmune hemolytic anemia substitutes anti-erythrocyte autoantibody and complement at the trigger and central-effector nodes. The generic effector cell at the destruction node is the macrophage (CL:0000235), representing the splenic red-pulp macrophage that performs erythrophagocytosis.
Reduced Erythrocyte Integrity
trigger
The cascade is initiated by an intrinsic red blood cell defect (membrane or cytoskeletal protein abnormality, enzyme deficiency, or abnormal hemoglobin) or by an extrinsic antibody-mediated, complement-mediated, or mechanical insult. The nature of the lesion varies by disorder, but each compromises erythrocyte integrity and deformability and renders the cell vulnerable to premature removal from the circulation.
Downstream
-
Oxidative and Membrane Injury
Show evidence (2 references)
"Disorders of red blood cell enzymes, membranes, and hemoglobin cause hereditary hemolytic anemias. Glucose-6-phosphate dehydrogenase deficiency leads to hemolysis in the presence of oxidative stress."
Review establishes that intrinsic defects of red cell enzymes, membranes, and hemoglobin are the conserved initiating lesions of hereditary hemolytic anemia, with G6PD deficiency exemplifying the oxidative-stress trigger. Evidence source is OTHER because this is a review synthesizing multiple study types.
"The causes of hereditary spherocytosis are mutations in genes that encode red blood cell (RBC) membrane and cytoskeletal proteins, including ankyrin-1, Band 3 (or AE1), α spectrin, β spectrin, and protein 4.2. Molecular defects in these proteins decrease membrane integrity, leading to..."
Provides a representative intrinsic-lesion example: membrane/cytoskeletal protein defects reduce membrane integrity and deformability, the generic trigger state of this module. Evidence source is OTHER because this is a review article.
Oxidative and Membrane Injury
amplifier
The primary lesion is amplified by oxidative damage and progressive injury to the erythrocyte membrane and cytoskeleton. Reactive oxygen species, impaired antioxidant defenses, hemoglobin denaturation (Heinz bodies), and loss of membrane surface area reduce deformability and expose removal signals such as phosphatidylserine, marking the cell for clearance.
Downstream
-
Premature Erythrocyte Destruction
Show evidence (2 references)
"The increased susceptibility of G6PD-deficient erythrocytes to membrane protein aspartate damage in response to oxidative stress suggests the involvement of protein deamidation/isomerization in the mechanisms of cell injury and haemolysis."
Direct experimental evidence that oxidative stress amplifies membrane protein damage in vulnerable erythrocytes, linking oxidative injury to the mechanism of hemolysis.
"Molecular defects in these proteins decrease membrane integrity, leading to vesiculation, decreased membrane surface area, and reduced deformability of the cells."
Establishes that membrane injury and loss of surface area reduce deformability, the conserved amplification step that primes cells for removal. Evidence source is OTHER because this is a review article.
Premature Erythrocyte Destruction
central effector
Damaged, poorly deformable, or antibody/complement-opsonized erythrocytes are destroyed prematurely. Extravascularly, splenic red-pulp macrophages recognize removal signals (phosphatidylserine exposure, bound immunoglobulin, or complement opsonins) and perform erythrophagocytosis; intravascularly, complement-mediated lysis or mechanical fragmentation destroys cells within the circulation. This is the central effector step shared across hereditary and acquired hemolytic anemias.
Used by disorders
HELLP Syndrome
as Microangiopathic Erythrocyte Fragmentation and Destruction
Downstream
-
Shortened Erythrocyte Lifespan and Erythropoietic Strain
Show evidence (2 references)
"PROS1 enhances the phagocytosis of ionomycin-treated PtdSer-positive erythrocytes and of eryghosts generated in vitro."
Demonstrates that phosphatidylserine-exposing altered erythrocytes are cleared by macrophage phagocytosis, the extravascular destruction mechanism central to this module.
"In wAIHA, IgG autoantibody reacts with autologous RBCs at 37 °C, leading to antibody-dependent cell-mediated cytotoxicity and increased phagocytosis of RBCs in the spleen."
Establishes that, in the acquired antibody-mediated arm, opsonized erythrocytes converge on the same splenic phagocytic destruction pathway. Evidence source is OTHER because this is a review (Nature Reviews Disease Primers) synthesizing multiple study types.
Shortened Erythrocyte Lifespan and Erythropoietic Strain
effector
Accelerated destruction shortens the erythrocyte lifespan and releases hemoglobin and its breakdown products (unconjugated bilirubin). The bone marrow responds with compensatory erythropoiesis and reticulocytosis, but in severe disease, or where erythropoiesis is itself ineffective (as in thalassemia), production cannot keep pace with loss, so red cell mass falls.
Show evidence (2 references)
"In beta thalassemia, unbalanced alpha globin chain synthesis results in severely rheologically compromised erythrocytes with premature destruction in the peripheral circulation and ineffective erythropoiesis within the bone marrow and in extramedullary sites."
Directly couples premature peripheral destruction with the erythropoietic response, illustrating that compensatory (and in thalassemia ineffective) erythropoiesis fails to maintain red cell mass. Evidence source is OTHER because this is a review article.
"Nevertheless, splenectomy increases the lifespan of red cells, significantly reducing the severity of anemia and improving many physiological signs of HS."
Shows that erythrocyte lifespan is the proximate determinant of anemia severity: lengthening lifespan (by removing the destruction site) reduces anemia. Evidence source is OTHER because this is a review article.
Hemolytic Anemia
consequence
When the rate of erythrocyte destruction exceeds the rate of compensatory production, red cell mass and hemoglobin fall, producing anemia. The hemolytic state is clinically recognized by anemia together with reticulocytosis, jaundice from increased unconjugated bilirubin, and often splenomegaly. This is the convergent disease-like phenotype (HP:0001878, MONDO:0002280) shared across all conforming disorders.
Show evidence (1 reference)
"Hemolysis presents as acute or chronic anemia, reticulocytosis, or jaundice. The diagnosis is established by reticulocytosis, increased unconjugated bilirubin and lactate dehydrogenase, decreased haptoglobin, and peripheral blood smear findings. Premature destruction of erythrocytes occurs..."
Defines the consequence node: premature erythrocyte destruction produces anemia with reticulocytosis and jaundice, the convergent hemolytic anemia phenotype. Evidence source is OTHER because this is a review.